In March 2025, the company introduced new strategies for the immediate-to-shopper offering of its Wegovy weight loss drug. The company established a brand new pharmacy, identified as NovoCare, which would charge buyers $499 every month for use of the drug, fewer than half the expense of the drug through other pharmaceutical distribution networks.[f… Read More